Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Suncor Energy Inc. — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.98 (market cap $1.74B), while Suncor Energy Inc. trades at $72.18 (market cap $82.76B). The key difference: Suncor Energy Inc. is far larger — about 47.6× Nuvation Bio Inc. Class A Common Stock's market cap, and Suncor Energy Inc. pays a 2.39% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Suncor Energy Inc. for 57 Days on average.
| NUVB | SU | |
|---|---|---|
Market Cap | $1.74B | $82.76B |
Volume | 9,289,619 | 3,832,959 |
Sector | Health | Energy |
52-Week High | $9.54 | $71.87 |
52-Week Low | $3.41 | $38.17 |
Typical Hold Time | 1 Days | 57 Days |
Enterprise Value | $1.33B | $89.29B |
Dividend Yield | — | 2.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Suncor Energy (SU) trades at $72.17, up 5.91% in the past 24 hours and near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, though the RSI suggests mild overbought conditions. Fundamentally, the company maintains solid profitability with a 14.7% net income margin and a reasonable P/E of 13.46. Recent news highlights asset divestments and a CEO transition, while analyst consensus is strongly positive with 74% buy ratings.
The outlook for SU is favorable, supported by robust cash flow, aggressive shareholder returns, and a discounted valuation relative to peers. Key opportunities include global refining strength and debt reduction, while risks involve commodity price volatility and operational challenges. The stock's momentum and fundamental health suggest potential for continued upside, contingent on stable energy markets and execution of strategic initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
